These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38587189)

  • 21. The chromatin remodelling factor ATRX suppresses R-loops in transcribed telomeric repeats.
    Nguyen DT; Voon HPJ; Xella B; Scott C; Clynes D; Babbs C; Ayyub H; Kerry J; Sharpe JA; Sloane-Stanley JA; Butler S; Fisher CA; Gray NE; Jenuwein T; Higgs DR; Gibbons RJ
    EMBO Rep; 2017 Jun; 18(6):914-928. PubMed ID: 28487353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The exoribonuclease XRN2 mediates degradation of the long non-coding telomeric RNA TERRA.
    Reiss M; Keegan J; Aldrich A; Lyons SM; Flynn RL
    FEBS Lett; 2023 Jul; 597(14):1818-1836. PubMed ID: 37191774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resolving Roadblocks to Telomere Replication.
    Mason-Osann E; Gali H; Flynn RL
    Methods Mol Biol; 2019; 1999():31-57. PubMed ID: 31127568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FANCM limits ALT activity by restricting telomeric replication stress induced by deregulated BLM and R-loops.
    Silva B; Pentz R; Figueira AM; Arora R; Lee YW; Hodson C; Wischnewski H; Deans AJ; Azzalin CM
    Nat Commun; 2019 May; 10(1):2253. PubMed ID: 31138795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The G-quadruplex ligand telomestatin impairs binding of topoisomerase IIIalpha to G-quadruplex-forming oligonucleotides and uncaps telomeres in ALT cells.
    Temime-Smaali N; Guittat L; Sidibe A; Shin-ya K; Trentesaux C; Riou JF
    PLoS One; 2009 Sep; 4(9):e6919. PubMed ID: 19742304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomere length heterogeneity in ALT cells is maintained by PML-dependent localization of the BTR complex to telomeres.
    Loe TK; Li JSZ; Zhang Y; Azeroglu B; Boddy MN; Denchi EL
    Genes Dev; 2020 May; 34(9-10):650-662. PubMed ID: 32217664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TERRA recruitment of polycomb to telomeres is essential for histone trymethylation marks at telomeric heterochromatin.
    Montero JJ; López-Silanes I; Megías D; F Fraga M; Castells-García Á; Blasco MA
    Nat Commun; 2018 Apr; 9(1):1548. PubMed ID: 29670078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-Myc quadruplex-forming sequence Pu-27 induces extensive damage in both telomeric and nontelomeric regions of DNA.
    Islam MA; Thomas SD; Murty VV; Sedoris KJ; Miller DM
    J Biol Chem; 2014 Mar; 289(12):8521-31. PubMed ID: 24464582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telomeric repeat-containing RNA/G-quadruplex-forming sequences cause genome-wide alteration of gene expression in human cancer cells in vivo.
    Hirashima K; Seimiya H
    Nucleic Acids Res; 2015 Feb; 43(4):2022-32. PubMed ID: 25653161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PML induces compaction, TRF2 depletion and DNA damage signaling at telomeres and promotes their alternative lengthening.
    Osterwald S; Deeg KI; Chung I; Parisotto D; Wörz S; Rohr K; Erfle H; Rippe K
    J Cell Sci; 2015 May; 128(10):1887-900. PubMed ID: 25908860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA.
    Fasching CL; Neumann AA; Muntoni A; Yeager TR; Reddel RR
    Cancer Res; 2007 Aug; 67(15):7072-7. PubMed ID: 17652140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative lengthening of telomeres (ALT) cells viability is dependent on C-rich telomeric RNAs.
    Rosso I; Jones-Weinert C; Rossiello F; Cabrini M; Brambillasca S; Munoz-Sagredo L; Lavagnino Z; Martini E; Tedone E; Garre' M; Aguado J; Parazzoli D; Mione M; Shay JW; Mercurio C; d'Adda di Fagagna F
    Nat Commun; 2023 Nov; 14(1):7086. PubMed ID: 37925537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen Breakage Syndrome 1.
    Wu G; Jiang X; Lee WH; Chen PL
    Cancer Res; 2003 May; 63(10):2589-95. PubMed ID: 12750284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clustered telomeres in phase-separated nuclear condensates engage mitotic DNA synthesis through BLM and RAD52.
    Min J; Wright WE; Shay JW
    Genes Dev; 2019 Jul; 33(13-14):814-827. PubMed ID: 31171703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative Lengthening of Telomeres through Two Distinct Break-Induced Replication Pathways.
    Zhang JM; Yadav T; Ouyang J; Lan L; Zou L
    Cell Rep; 2019 Jan; 26(4):955-968.e3. PubMed ID: 30673617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long interspersed element-1 ribonucleoprotein particles protect telomeric ends in alternative lengthening of telomeres dependent cells.
    Aschacher T; Wolf B; Aschacher O; Enzmann F; Laszlo V; Messner B; Türkcan A; Weis S; Spiegl-Kreinecker S; Holzmann K; Laufer G; Ehrlich M; Bergmann M
    Neoplasia; 2020 Feb; 22(2):61-75. PubMed ID: 31846834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomerase suppresses formation of ALT-associated single-stranded telomeric C-circles.
    Plantinga MJ; Pascarelli KM; Merkel AS; Lazar AJ; von Mehren M; Lev D; Broccoli D
    Mol Cancer Res; 2013 Jun; 11(6):557-67. PubMed ID: 23505069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomeric replication stress: the beginning and the end for alternative lengthening of telomeres cancers.
    Lu R; Pickett HA
    Open Biol; 2022 Mar; 12(3):220011. PubMed ID: 35259951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference.
    Jiang WQ; Zhong ZH; Henson JD; Reddel RR
    Oncogene; 2007 Jul; 26(32):4635-47. PubMed ID: 17297460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New twists to the ALTernative endings at telomeres.
    Bhargava R; Lynskey ML; O'Sullivan RJ
    DNA Repair (Amst); 2022 Jul; 115():103342. PubMed ID: 35588569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.